Well then write up these results as a protocol that doesn't work and distribute it to all 10 million yearly stroke survivors. The top down method does not work.
Exploratory randomized double-blind placebo-controlled trial of botulinum therapy on grasp release after stroke (PrOMBiS)
Neurorehabilitation and Neural Repair (NNR) , Volume 34(1) , Pgs. 51-60.NARIC Accession Number: J82902. What's this?
ISSN: 1545-9683.
Author(s): Wallace, Amanda C.; Talelli, Penelope; Crook, Lucinda ; Austin, Duncan ; Farrell, Rachel ; Hoad, Damon ; O’Keeffe, Aidan G.; Marsden, Jonathan F. ; Fitzpatrick, Richard ; Greenwood, Richard ; Rothwell, John C. ; Werring, David J..
Publication Year: 2020.
Number of Pages: 10.
Abstract:
PROMBIS (Predicting Outcomes and Measuring benefit of Botulinum therapy in Stroke) is an exploratory randomized, double-blind, placebo-controlled, parallel-group trial to investigate the effect of onabotulinumtoxinA on one such specific outcome: grasp-release time. The study determined whether a single treatment with onabotulinumtoxinA injections combined with upper-limb physiotherapy improves grasp release compared with physiotherapy alone after stroke. Twenty-eight patients, at least 1 month post stroke, were randomized to receive either onabotulinumtoxinA or placebo injections to the affected upper limb followed by standardized upper-limb physiotherapy (10 sessions over 4 weeks). The primary outcome was time to release grasp during a functionally relevant standardized task. Secondary outcomes included measures of wrist and finger spasticity and strength using a customized servomotor, clinical assessments of stiffness (modified Ashworth Scale), arm function (Action Research Arm Test [ARAT], Nine Hole Peg Test), arm use (Arm Measure of Activity), Goal Attainment Scale, and quality of life (EQ5D). There was no significant difference between treatment groups in grasp release time 5 weeks post injection. None of the secondary measures passed significance after correcting for multiple comparisons. Both groups achieved their treatment goals and made improvements on the ARAT and in active wrist extension. In this group of stroke patients with mild-to-moderate spastic hemiparesis, a single treatment with onabotulinumtoxinA did not augment the improvements seen in grasp release time after a standardized upper-limb physiotherapy program.Descriptor Terms: DEXTERITY, INTERVENTION, LIMBS, PHARMACOLOGY, PHYSICAL THERAPY, SPASTICITY, STROKE, TASK ANALYSIS.
Can this document be ordered through NARIC's document delivery service*?: Y.
Citation: Wallace, Amanda C., Talelli, Penelope, Crook, Lucinda , Austin, Duncan , Farrell, Rachel , Hoad, Damon , O’Keeffe, Aidan G., Marsden, Jonathan F. , Fitzpatrick, Richard , Greenwood, Richard , Rothwell, John C. , Werring, David J.. (2020). Exploratory randomized double-blind placebo-controlled trial of botulinum therapy on grasp release after stroke (PrOMBiS). Neurorehabilitation and Neural Repair (NNR) , 34(1), Pgs. 51-60. Retrieved 3/16/2020, from REHABDATA database.
* The majority of journal articles, books, and reports in our collection are only available by regular mail, rather than downloadable electronic format. Learn more about our digital collection and our document delivery service.
No comments:
Post a Comment